Enzolytics(ENZC)
$0.00-0.00 (-25.00%)
ENZC
Enzolytics financials statements
$0.00
At close:-0.00 (-25.00%)
Enzolytics (ENZC) Ratios
464 Followers
Enzolytics Ratios
ENZC's free cash flow for Q2 2024 was $114.84M. For the 2024 fiscal year, ENZC's free cash flow was increased by $0.00 and operating cash flow was $114.84M. See a summary of the company’s cash flow.
| Ratios | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.63 | 0.99 | 0.12 | 0.49 | 0.11 |
| Quick Ratio | 0.63 | 0.99 | 0.12 | 0.49 | 0.11 |
| Cash Ratio | 0.00 | 0.00 | 0.12 | 0.49 | 0.11 |
| Solvency Ratio | -0.00 | -0.01 | -0.52 | -0.12 | -0.58 |
| Operating Cash Flow Ratio | -0.00 | -0.00 | -0.56 | -0.28 | -0.10 |
| Short-Term Operating Cash Flow Coverage | -0.57 | -0.88 | -2.26 | -0.97 | -0.44 |
| Net Current Asset Value | $ -120.25M | $ -5.25M | $ -5.04M | $ -3.25M | $ -5.38M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.52 | 0.42 | 1.95 |
| Debt-to-Equity Ratio | -0.01 | -0.28 | -0.35 | -0.59 | -0.21 |
| Debt-to-Capital Ratio | -0.01 | -0.39 | -0.55 | -1.44 | -0.26 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -1.70 | -101.53 | -0.68 | -1.41 | -0.11 |
| Debt Service Coverage Ratio | -0.32 | -2.07 | -2.37 | -0.44 | -2.56 |
| Interest Coverage Ratio | -9.69 | -77.53 | -77.82 | -37.80 | -18.63 |
| Debt to Market Cap | 0.81 | 0.02 | 0.01 | 0.01 | 0.01 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | -2.97 | -0.46 | -0.22 | 1.52 | -0.17 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 58.16% | 0.00% | 91.52% | 0.00% |
| EBIT Margin | 0.00% | -4061.14% | 0.00% | -316.00% | 0.00% |
| EBITDA Margin | 0.00% | -4019.30% | 0.00% | -306.00% | 0.00% |
| Operating Profit Margin | 0.00% | -4070.01% | 0.00% | -705.50% | 0.00% |
| Pretax Profit Margin | 0.00% | -4123.10% | 0.00% | -334.50% | 0.00% |
| Net Profit Margin | 0.00% | -4123.10% | 0.00% | -334.50% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | -4123.10% | 0.00% | -334.50% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 110.36% | 101.30% | 101.27% | 47.41% | 105.39% |
| Return on Assets (ROA) | -0.20% | -0.60% | -129.66% | -20.66% | -612.41% |
| Return on Equity (ROE) | 0.33% | 61.11% | 88.47% | 29.22% | 64.82% |
| Return on Capital Employed (ROCE) | 0.30% | 79.70% | 118.16% | 99.13% | 73.34% |
| Return on Invested Capital (ROIC) | 0.31% | 126.43% | 227.15% | 1946.74% | 97.23% |
| Return on Tangible Assets | -0.20% | -0.60% | -129.66% | -20.66% | -612.41% |
| Earnings Yield | -32.11% | -4.25% | -2.82% | -0.35% | -4.62% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.10 | 0.09 | 0.07 | 0.08 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.50 | 0.00 | 1.33 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.06 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | -0.01 | 0.00 | -0.06 | 0.00 |
| Cash Conversion Cycle | 0.00 | -3643.77 | -3909.34 | -5465.58 | -4789.15 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 3643.77 | 3909.34 | 5465.58 | 4789.15 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -293359.00 | 0.00 | -7.87 | -122753.50 |
| Capital Expenditure Coverage Ratio | 0.00 | -293359.00 | 0.00 | -7.87 | -122753.50 |
| Operating Cash Flow Coverage Ratio | -0.57 | -0.88 | -2.26 | -0.97 | -0.44 |
| Operating Cash Flow to Sales Ratio | 0.00 | -16.67 | 0.00 | -6.53 | 0.00 |
| Free Cash Flow Yield | -45.88% | -1.72% | -2.55% | -0.76% | -0.65% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -3.17 | -23.52 | -35.42 | -288.58 | -21.63 |
| Price-to-Sales (P/S) Ratio | 0.00 | 969.55 | 0.00 | 965.29 | 0.00 |
| Price-to-Book (P/B) Ratio | -0.01 | -14.37 | -31.33 | -84.31 | -14.02 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.18 | -58.16 | -39.15 | -131.13 | -153.37 |
| Price-to-Operating Cash Flow Ratio | -2.18 | -58.16 | -39.15 | -147.78 | -153.37 |
| Price-to-Earnings Growth (PEG) Ratio | 0.06 | 0.78 | -0.09 | 3.06 | 0.05 |
| Enterprise Value Multiple | -6.64 | -24.58 | -36.36 | -313.93 | -23.08 |
| Enterprise Value | 2.22M | 52.17M | 104.78M | 192.13M | 75.85M |
| EV to EBITDA | -6.64 | -24.58 | -36.36 | -313.93 | -23.08 |
| EV to Sales | 0.00 | 988.14 | 0.00 | 960.63 | 0.00 |
| EV to Free Cash Flow | -3.95 | -59.28 | -39.38 | -130.49 | -154.49 |
| EV to Operating Cash Flow | -3.95 | -59.28 | -39.38 | -147.07 | -154.49 |
| Tangible Book Value Per Share | -0.09 | -0.00 | -0.00 | -0.00 | -0.01 |
| Shareholders’ Equity Per Share | -0.09 | -0.00 | -0.00 | -0.00 | -0.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.10 | 1.02 | 1.01 | 1.06 | 1.05 |
| Research & Development to Revenue | 0.00 | 3.25 | 0.00 | 0.58 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.43 | 0.40 | 0.90 | 1.95 | 0.14 |
Currency in USD

